- Home
- DYAI vs NBY Comparison
DYAI vs NBY Comparison
Compare DYAI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYAI | NBY |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 31.6M |
| IPO Year | 2003 | 2007 |
Fundamental Metrics
Financial Performance| Metric | DYAI | NBY |
|---|---|---|
| Price | $0.88 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 78.1K | ★ 429.9K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $3,090,345.00 | $370,000.00 |
| Revenue This Year | $131.04 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $0.43 |
| 52 Week High | $1.35 | $19.95 |
Technical Indicators
Market Signals| Indicator | DYAI | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 54.36 | 57.82 |
| Support Level | $0.83 | $1.01 |
| Resistance Level | $1.00 | $2.52 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 74.69 | 96.45 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.